These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 15955014)

  • 1. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
    Brugal MT; Domingo-Salvany A; Puig R; Barrio G; García de Olalla P; de la Fuente L
    Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
    Dolan KA; Shearer J; White B; Zhou J; Kaldor J; Wodak AD
    Addiction; 2005 Jun; 100(6):820-8. PubMed ID: 15918812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.
    Davoli M; Bargagli AM; Perucci CA; Schifano P; Belleudi V; Hickman M; Salamina G; Diecidue R; Vigna-Taglianti F; Faggiano F;
    Addiction; 2007 Dec; 102(12):1954-9. PubMed ID: 18031430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increasing mortality burden of liver disease among opioid-dependent people: cohort study.
    Gibson A; Randall D; Degenhardt L
    Addiction; 2011 Dec; 106(12):2186-92. PubMed ID: 21749525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Tait RJ; Ngo HT; Hulse GK
    J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal overdoses and deaths by other causes in a cohort of Norwegian drug abusers--a competing risk approach.
    Ødegård E; Amundsen EJ; Kielland KB
    Drug Alcohol Depend; 2007 Jul; 89(2-3):176-82. PubMed ID: 17240086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.
    Stoové MA; Dietze PM; Jolley D
    Drug Alcohol Rev; 2009 Jul; 28(4):347-52. PubMed ID: 19594787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].
    Muga R; Egea JM; Navío M; Sirera G; Vall M; Tor J
    Med Clin (Barc); 1999 May; 112(19):721-5. PubMed ID: 10394568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trend of mortality observed in a cohort of drug addicts of the metropolitan area of Bologna, North-Eastern Italy, during a 25-year-period.
    Manfredi R; Sabbatani S; Agostini D
    Coll Antropol; 2006 Sep; 30(3):479-88. PubMed ID: 17058511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonfatal overdose among heroin users in southwestern China.
    Yin L; Qin G; Ruan Y; Qian HZ; Hao C; Xie L; Chen K; Zhang Y; Xia Y; Wu J; Lai S; Shao Y
    Am J Drug Alcohol Abuse; 2007; 33(4):505-16. PubMed ID: 17668336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mortality and HIV infection in a group of intravenous heroin addicts from 1985 to 1989].
    Delvecchio G; Brancato V
    Minerva Med; 1991 Oct; 82(10):675-8. PubMed ID: 1745378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug use and HIV/AIDS in China.
    Liu Z; Lian Z; Zhao C
    Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mortality and causes of death among intravenous drug addicts in Oslo].
    Eskild A; Magnus P; Samuelsen SO; Sohlberg C; Kittelsen P
    Tidsskr Nor Laegeforen; 1993 Apr; 113(11):1331-3. PubMed ID: 8337619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in heroin-assisted treatment in Switzerland 1994-2000.
    Rehm J; Frick U; Hartwig C; Gutzwiller F; Gschwend P; Uchtenhagen A
    Drug Alcohol Depend; 2005 Aug; 79(2):137-43. PubMed ID: 16002023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overdose deaths attributed to methadone and heroin in New York City, 1990-1998.
    Bryant WK; Galea S; Tracy M; Markham Piper T; Tardiff KJ; Vlahov D
    Addiction; 2004 Jul; 99(7):846-54. PubMed ID: 15200580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments].
    Lepère B; Gourarier L; Sanchez M; Adda C; Peyret E; Nordmann F; Ben Soussen P; Gisselbrecht M; Lowenstein W
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS5-12. PubMed ID: 11435989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
    Kerr T; Marsh D; Li K; Montaner J; Wood E
    Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences.
    Jimenez-Treviño L; Saiz PA; García-Portilla MP; Díaz-Mesa EM; Sánchez-Lasheras F; Burón P; Casares MJ; Marina P; Gutiérrez E; Bobes J
    Addict Behav; 2011 Dec; 36(12):1184-90. PubMed ID: 21835551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.